New bull's-eyes for drugs.
Kenakin
Terry
T
GlaxoSmithKline.
D000494:Allosteric Regulation; D003920:Diabetes Mellitus / Q000188:drug therapy; D015195:Drug Design; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009765:Obesity / Q000188:drug therapy; D011487:Protein Conformation; D043562:Receptors, G-Protein-Coupled / Q000737:chemistry / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D015398:Signal Transduction; D013678:Technology, Pharmaceutical
D043562:Receptors, G-Protein-Coupled